Miyake M, Nishimura N, Oda Y, Miyamoto T, et al. Enfortumab vedotin following platinum-based chemotherapy and immune checkpoint inhibitors for advanced urothelial carcinoma: response, survival and safety analysis from a multicentre real-world Japanese cohort. Jpn J Clin Oncol 2024;54:329-338.
PMID: 38061911